메뉴 건너뛰기




Volumn 100, Issue 6, 2015, Pages 667-679

Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CONNEXIN 43; ENALAPRIL; MALONALDEHYDE; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA; VILDAGLIPTIN; ADAMANTANE; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DPP4 PROTEIN, RAT; NITRILE; PYRROLIDINE DERIVATIVE;

EID: 84930572996     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085108     Document Type: Article
Times cited : (33)

References (51)
  • 1
    • 84874434735 scopus 로고    scopus 로고
    • Post-infarction inflammation and left ventricular remodeling: a double-edged sword
    • Anzai T (2013). Post-infarction inflammation and left ventricular remodeling: a double-edged sword. Circ J 77, 580-587.
    • (2013) Circ J , vol.77 , pp. 580-587
    • Anzai, T.1
  • 2
    • 84904540452 scopus 로고    scopus 로고
    • Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats
    • Apaijai N, Chinda K, Palee S, Chattipakorn S & Chattipakorn N (2014). Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats. PLoS ONE 9, e102374.
    • (2014) PLoS ONE , vol.9 , pp. e102374
    • Apaijai, N.1    Chinda, K.2    Palee, S.3    Chattipakorn, S.4    Chattipakorn, N.5
  • 3
    • 84864382843 scopus 로고    scopus 로고
    • Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet
    • Apaijai N, Pintana H, Chattipakorn SC & Chattipakorn N (2012). Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet. Endocrinology 153, 3878-3885.
    • (2012) Endocrinology , vol.153 , pp. 3878-3885
    • Apaijai, N.1    Pintana, H.2    Chattipakorn, S.C.3    Chattipakorn, N.4
  • 4
    • 84879030222 scopus 로고    scopus 로고
    • Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats
    • Apaijai N, Pintana H, Chattipakorn SC & Chattipakorn N (2013). Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats. Br J Pharmacol 169, 1048-1057.
    • (2013) Br J Pharmacol , vol.169 , pp. 1048-1057
    • Apaijai, N.1    Pintana, H.2    Chattipakorn, S.C.3    Chattipakorn, N.4
  • 5
    • 0035964390 scopus 로고    scopus 로고
    • Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction
    • Bauersachs J, Galuppo P, Fraccarollo D, Christ M & Ertl G (2001). Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction. Circulation 104, 982-985.
    • (2001) Circulation , vol.104 , pp. 982-985
    • Bauersachs, J.1    Galuppo, P.2    Fraccarollo, D.3    Christ, M.4    Ertl, G.5
  • 6
    • 34047148354 scopus 로고    scopus 로고
    • The role of TGF-β signaling in myocardial infarction and cardiac remodeling
    • Bujak M & Frangogiannis NG (2007). The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74, 184-195.
    • (2007) Cardiovasc Res , vol.74 , pp. 184-195
    • Bujak, M.1    Frangogiannis, N.G.2
  • 7
    • 34248368106 scopus 로고    scopus 로고
    • Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators
    • Bunch TJ, Hohnloser SH & Gersh BJ (2007). Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Circulation 115, 2451-2457.
    • (2007) Circulation , vol.115 , pp. 2451-2457
    • Bunch, T.J.1    Hohnloser, S.H.2    Gersh, B.J.3
  • 9
    • 84864380749 scopus 로고    scopus 로고
    • Cardioprotective effects of incretin during ischaemia-reperfusion
    • Chinda K, Chattipakorn S & Chattipakorn N (2012). Cardioprotective effects of incretin during ischaemia-reperfusion. Diab Vasc Dis Res 9, 256-269.
    • (2012) Diab Vasc Dis Res , vol.9 , pp. 256-269
    • Chinda, K.1    Chattipakorn, S.2    Chattipakorn, N.3
  • 11
    • 0034162004 scopus 로고    scopus 로고
    • Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
    • Cohn JN, Ferrari R & Sharpe N, on behalf of an International Forum on Cardiac Remodeling (2000). Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol 35, 569-582.
    • (2000) J Am Coll Cardiol , vol.35 , pp. 569-582
    • Cohn, J.N.1    Ferrari, R.2    Sharpe, N.3
  • 12
    • 8844235617 scopus 로고    scopus 로고
    • The mitochondrial death pathway and cardiac myocyte apoptosis
    • Crow MT, Mani K, Nam YJ & Kitsis RN (2004). The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95, 957-970.
    • (2004) Circ Res , vol.95 , pp. 957-970
    • Crow, M.T.1    Mani, K.2    Nam, Y.J.3    Kitsis, R.N.4
  • 13
    • 80052819014 scopus 로고    scopus 로고
    • Transforming growth factor (TGF)-β signaling in cardiac remodeling
    • Dobaczewski M, Chen W & Frangogiannis NG (2011). Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol 51, 600-606.
    • (2011) J Mol Cell Cardiol , vol.51 , pp. 600-606
    • Dobaczewski, M.1    Chen, W.2    Frangogiannis, N.G.3
  • 15
    • 78650985392 scopus 로고    scopus 로고
    • Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities
    • Gajarsa JJ & Kloner RA (2011). Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 16, 13-21.
    • (2011) Heart Fail Rev , vol.16 , pp. 13-21
    • Gajarsa, J.J.1    Kloner, R.A.2
  • 16
    • 0029257791 scopus 로고
    • Rat infarct model of myocardial infarction and heart failure
    • Goldman S & Raya TE (1995). Rat infarct model of myocardial infarction and heart failure. J Card Fail 1, 169-177.
    • (1995) J Card Fail , vol.1 , pp. 169-177
    • Goldman, S.1    Raya, T.E.2
  • 17
    • 0346328578 scopus 로고    scopus 로고
    • Oxidative stress in heart failure. More than just damage
    • Grieve DJ & Shah AM (2003). Oxidative stress in heart failure. More than just damage. Eur Heart J 24, 2161-2163.
    • (2003) Eur Heart J , vol.24 , pp. 2161-2163
    • Grieve, D.J.1    Shah, A.M.2
  • 18
    • 67650223772 scopus 로고    scopus 로고
    • GLP-1 therapy: beyond glucose control
    • Hausenloy DJ & Yellon DM (2008). GLP-1 therapy: beyond glucose control. Circ Heart Fail 1, 147-149.
    • (2008) Circ Heart Fail , vol.1 , pp. 147-149
    • Hausenloy, D.J.1    Yellon, D.M.2
  • 19
    • 84865576863 scopus 로고    scopus 로고
    • Renal and cardiac effects of DPP4 inhibitors - from preclinical development to clinical research
    • Hocher B, Reichetzeder C & Alter ML (2012). Renal and cardiac effects of DPP4 inhibitors - from preclinical development to clinical research. Kidney Blood Press Res 36, 65-84.
    • (2012) Kidney Blood Press Res , vol.36 , pp. 65-84
    • Hocher, B.1    Reichetzeder, C.2    Alter, M.L.3
  • 21
    • 0036238790 scopus 로고    scopus 로고
    • Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats
    • Izutani S, Yoshiyama M, Omura T, Yoshida K, Nakamura Y, Kim S, Takeuchi K & Yoshikawa J (2002). Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats. Circ J 66, 289-293.
    • (2002) Circ J , vol.66 , pp. 289-293
    • Izutani, S.1    Yoshiyama, M.2    Omura, T.3    Yoshida, K.4    Nakamura, Y.5    Kim, S.6    Takeuchi, K.7    Yoshikawa, J.8
  • 22
    • 84857451392 scopus 로고    scopus 로고
    • Heart failure as an autonomic nervous system dysfunction
    • Kishi T (2012). Heart failure as an autonomic nervous system dysfunction. J Cardiol 59, 117-122.
    • (2012) J Cardiol , vol.59 , pp. 117-122
    • Kishi, T.1
  • 23
    • 78651386028 scopus 로고    scopus 로고
    • Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment
    • Konstam MA, Kramer DG, Patel AR, Maron MS & Udelson JE (2011). Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging 4, 98-108.
    • (2011) JACC Cardiovasc Imaging , vol.4 , pp. 98-108
    • Konstam, M.A.1    Kramer, D.G.2    Patel, A.R.3    Maron, M.S.4    Udelson, J.E.5
  • 25
    • 77449101661 scopus 로고    scopus 로고
    • A chemical genetic approach reveals that p38α MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580
    • Kumphune S, Bassi R, Jacquet S, Sicard P, Clark JE, Verma S, Avkiran M, O'Keefe SJ & Marber MS (2011). A chemical genetic approach reveals that p38α MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. J Biol Chem 285, 2968-2975.
    • (2011) J Biol Chem , vol.285 , pp. 2968-2975
    • Kumphune, S.1    Bassi, R.2    Jacquet, S.3    Sicard, P.4    Clark, J.E.5    Verma, S.6    Avkiran, M.7    O'Keefe, S.J.8    Marber, M.S.9
  • 26
    • 84864044989 scopus 로고    scopus 로고
    • Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate
    • Lekawanvijit S, Kompa AR, Manabe M, Wang BH, Langham RG, Nishijima F, Kelly DJ & Krum H (2012). Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate. PLoS ONE 7, e41281.
    • (2012) PLoS ONE , vol.7 , pp. e41281
    • Lekawanvijit, S.1    Kompa, A.R.2    Manabe, M.3    Wang, B.H.4    Langham, R.G.5    Nishijima, F.6    Kelly, D.J.7    Krum, H.8
  • 27
    • 84860522968 scopus 로고    scopus 로고
    • Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome
    • Lekawanvijit S, Kompa AR, Zhang Y, Wang BH, Kelly DJ & Krum H (2012). Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome. Am J Physiol Heart Circ Physiol 302, H1884-H1893.
    • (2012) Am J Physiol Heart Circ Physiol , vol.302 , pp. H1884-H1893
    • Lekawanvijit, S.1    Kompa, A.R.2    Zhang, Y.3    Wang, B.H.4    Kelly, D.J.5    Krum, H.6
  • 29
    • 78149493266 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
    • Liu Q, Anderson C, Broyde A, Polizzi C, Fernandez R, Baron A & Parkes DG (2010). Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure. Cardiovasc Diabetol 9, 76.
    • (2010) Cardiovasc Diabetol , vol.9 , pp. 76
    • Liu, Q.1    Anderson, C.2    Broyde, A.3    Polizzi, C.4    Fernandez, R.5    Baron, A.6    Parkes, D.G.7
  • 30
    • 0017262813 scopus 로고
    • Echocardiographic assessment of left ventricular function in aortic valve disease
    • McDonald IG (1976). Echocardiographic assessment of left ventricular function in aortic valve disease. Circulation 53, 860-864.
    • (1976) Circulation , vol.53 , pp. 860-864
    • McDonald, I.G.1
  • 31
    • 27644435941 scopus 로고    scopus 로고
    • Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits
    • Mateos R, Lecumberri E, Ramos S, Goya L & Bravo L (2005). Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci 827, 76-82.
    • (2005) J Chromatogr B Analyt Technol Biomed Life Sci , vol.827 , pp. 76-82
    • Mateos, R.1    Lecumberri, E.2    Ramos, S.3    Goya, L.4    Bravo, L.5
  • 33
    • 73049104933 scopus 로고    scopus 로고
    • Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo
    • Moreo A, Ambrosio G, DeChiara B, Pu M, Tran T, Mauri F & Raman SV (2009). Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2, 437-443.
    • (2009) Circ Cardiovasc Imaging , vol.2 , pp. 437-443
    • Moreo, A.1    Ambrosio, G.2    De Chiara, B.3    Pu, M.4    Tran, T.5    Mauri, F.6    Raman, S.V.7
  • 35
    • 3042702881 scopus 로고    scopus 로고
    • Inflammatory cytokines and postmyocardial infarction remodeling
    • Nian M, Lee P, Khaper N & Liu P (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94, 1543-1553.
    • (2004) Circ Res , vol.94 , pp. 1543-1553
    • Nian, M.1    Lee, P.2    Khaper, N.3    Liu, P.4
  • 38
    • 54049130023 scopus 로고    scopus 로고
    • Short-term heart variability and oxidative stress in newly diagnosed essential hypertension
    • Pavithran P, Nandeesha H, Sathiyapriya V, Bobby Z & Madanmohan T (2008). Short-term heart variability and oxidative stress in newly diagnosed essential hypertension. Clin Exp Hypertens 30, 486-496.
    • (2008) Clin Exp Hypertens , vol.30 , pp. 486-496
    • Pavithran, P.1    Nandeesha, H.2    Sathiyapriya, V.3    Bobby, Z.4    Madanmohan, T.5
  • 39
    • 81855184473 scopus 로고    scopus 로고
    • The incretin axis in cardiovascular disease
    • Plutzky J (2011). The incretin axis in cardiovascular disease. Circulation 124, 2285-2289.
    • (2011) Circulation , vol.124 , pp. 2285-2289
    • Plutzky, J.1
  • 42
    • 33845293219 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
    • Sokos GG, Nikolaidis LA, Mankad S, Elahi D & Shannon RP (2006). Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12, 694-699.
    • (2006) J Card Fail , vol.12 , pp. 694-699
    • Sokos, G.G.1    Nikolaidis, L.A.2    Mankad, S.3    Elahi, D.4    Shannon, R.P.5
  • 43
    • 84928698233 scopus 로고    scopus 로고
    • Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats
    • Supakul L, Pintana H, Apaijai N, Chattipakorn S, Shinlapawittayatorn K & Chattipakorn N (2014). Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats. Eur J Nutr 53, 919-928.
    • (2014) Eur J Nutr , vol.53 , pp. 919-928
    • Supakul, L.1    Pintana, H.2    Apaijai, N.3    Chattipakorn, S.4    Shinlapawittayatorn, K.5    Chattipakorn, N.6
  • 44
    • 0034720847 scopus 로고    scopus 로고
    • Left ventricular remodeling after myocardial infarction: pathophysiology and therapy
    • Sutton MG & Sharpe N (2000). Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101, 2981-2988.
    • (2000) Circulation , vol.101 , pp. 2981-2988
    • Sutton, M.G.1    Sharpe, N.2
  • 45
    • 34548658535 scopus 로고    scopus 로고
    • Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?
    • Tahrani AA, Varughese GI, Scarpello JH & Hanna FW (2007). Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ 335, 508-512.
    • (2007) BMJ , vol.335 , pp. 508-512
    • Tahrani, A.A.1    Varughese, G.I.2    Scarpello, J.H.3    Hanna, F.W.4
  • 48
    • 4644301090 scopus 로고    scopus 로고
    • Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan
    • Wang J, Guo X & Dhalla NS (2004). Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan. Biochim Biophys Acta 1690, 177-184.
    • (2004) Biochim Biophys Acta , vol.1690 , pp. 177-184
    • Wang, J.1    Guo, X.2    Dhalla, N.S.3
  • 50
    • 80053358548 scopus 로고    scopus 로고
    • Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
    • Yin M, Silljé HH, Meissner M, vanGilst WH & deBoer RA (2011). Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure. Cardiovasc Diabetol 10, 85.
    • (2011) Cardiovasc Diabetol , vol.10 , pp. 85
    • Yin, M.1    Silljé, H.H.2    Meissner, M.3    van Gilst, W.H.4    de Boer, R.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.